Nonprofit · EIN 76-0514428
MELANOMA RESEARCH FOUNDATION
Tax-exempt · WASHINGTON, DC 20005
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| March 31, 2025 | 990 | $7,413,825 | $6,905,774 | $508,051 | $8,283,039 | $3,344,115 | $4,938,924 |
| March 31, 2024 | 990 | $7,774,562 | $6,697,219 | $1,077,343 | $7,270,872 | $2,821,971 | $4,448,901 |
Financial details: 990 for the year ended March 31, 2025
Revenue
- Contributions, gifts and grants
- $8,089,338
- Program service revenue
- $0
- Investment income
- $118,973
- Net rental income
- $20,000
- Net gain from sales of assets
- $46,184
- Net income from fundraising events
- -$814,486
- Other revenue
- -$794,486
Expenses
- Grants and similar amounts paid
- $1,629,606
- Compensation of officers, directors and key employees
- $390,631
- Other salaries and wages
- $1,632,540
- Salaries, compensation and benefits (total)
- $2,363,261
- Professional fundraising fees
- $0
- Legal fees
- $5,879
- Accounting fees
- $258,888
- Occupancy
- $39,351
- Travel
- $279,927
- Depreciation
- $223,358
- Program services (functional)
- $4,922,556
- Management and general (functional)
- $1,085,707
- Fundraising (functional)
- $897,511
Balance sheet and other
- Total assets, start of year
- $7,270,872
- Total assets, end of year
- $8,283,039
- Total liabilities, end of year
- $3,344,115
- Net assets, end of year
- $4,938,924
- Land, buildings and equipment
- $212,708
- Publicly traded securities
- $3,378,893
- Net assets without donor restrictions
- $1,185,628
- Net assets with donor restrictions
- $3,753,296
- Gross receipts
- $8,638,859
- Employees
- 24
- Volunteers
- 340
- Year formed
- 1996
- State of legal domicile
- TX
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended March 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| KYLEIGH LIPIRA | CEO Trustee or director, Officer | 40 | $340,283 | $12,212 |
| JAMES MERRICK | CHIEF COMMUNICATIONS OFFICER Highest-paid employee | 40 | $159,361 | $12,250 |
| ELIZABETH REILLY SR DEVEL | OFFICER - ENDOWMENT & PLANNED GIVING Highest-paid employee | 40 | $121,058 | $18,815 |
| JESSICA ALLISON | DIRECTOR OF CORPORATE RELATIONS Highest-paid employee | 40 | $116,635 | $13,682 |
| DOUGLAS BRODMAN | CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| THOMAS WESTDYK | SECRETARY AND GOVERNANCE Trustee or director, Officer | 2 | $0 | $0 |
| JILL WROBEL | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| STAN ADLER | BOARD MEMBER - UNTIL 12/2024 Trustee or director | 1 | $0 | $0 |
| MICHAEL B ATKINS MD | SAC CO-CHAIR Trustee or director | 1 | $0 | $0 |
| ELISE BARISH | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| LAURA FERRIS MD | BOARD MEMBER - UNTIL 12/2024 Trustee or director | 1 | $0 | $0 |
| KRISTINA GARGIULO | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| REBECCA HARTMAN MD | BOARD MEMBER - AS OF 01/25 Trustee or director | 1 | $0 | $0 |
| MICHELLE HENRY MD | BOARD MEMBER - AS OF 01/25 Trustee or director | 1 | $0 | $0 |
| GIULIA NEWTON | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
2 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| PATTY POPHAL | BOARD MEMBER - AS OF 01/25 Trustee or director | 1 | $0 |
| ASHANI WEERARATNA MD | SAC CO-CHAIR Trustee or director | 1 | $0 |
990 for the year ended March 31, 2024: 16 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| KYLEIGH LIPIRA | CEO Trustee or director, Officer | 40 | $336,485 | $11,196 |
| JAMES MERRICK | CHIEF COMMUNICATIONS OFFICER Highest-paid employee | 40 | $178,462 | $8,755 |
| JESSICA ALLISON | DIRECTOR OF CORPORATE RELATIONS Highest-paid employee | 40 | $114,686 | $10,907 |
| DOUGLAS BRODMAN | CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| ALISON MARTIN MD | VICE CHAIR - UNTIL 01/2024 Trustee or director, Officer | 2 | $0 | $0 |
| THOMAS WESTDYK SECRETARY | AND GOVERNANCE - AS OF 01/2024 Trustee or director, Officer | 2 | $0 | $0 |
| CHERUL STRATOS | SECRETARY - UNTIL 12/2023 Trustee or director, Officer | 2 | $0 | $0 |
| JILL WROBEL | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| STAN ADLER | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| MICHAEL B ATKINS MD | SAC CO-CHAIR Trustee or director | 1 | $0 | $0 |
| ELISE BARISH | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| KRISTINA BAUM | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| LAURA FERRIS MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| GLENN MERLINO | SAC CO-CHAIR - UNTIL 12/2023 Trustee or director | 1 | $0 | $0 |
| GIULIA NEWTON | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ASHANI WEERARATNA MD | SAC CO-CHAIR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1420 K ST NW STE 700, WASHINGTON, DC 20005-2516
- Principal officer (990 for 2024)
- KYLEIGH LIPIRA, 1420 K STREET NW 7TH FLOOR, WASHINGTON, DC 20005
- Signed the 990
- KYLEIGH LIPIRA, CEO
- Phone
- (202) 347-9675
- Website
- WWW.MELANOMA.ORG
- Return prepared by
- CBIZ ADVISORS LLC
Mission
THE MRF IS THE LARGEST INDEPENDENT ORGANIZATION DEVOTED TO MELANOMA. ITS MISSION IS TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING AND ADVOCATING FOR THE MELANOMA COMMUNITY.
Program accomplishments
- THE MRF IS COMMITTED TO ADVANCING A BROAD SCIENTIFIC AGENDA ACROSS THE DISCIPLINES OF PREVENTION, DIAGNOSIS, AND TREATMENT. ALTHOUGH THE MRF HAS ACHIEVED A NUMBER OF IMPORTANT SCIENTIFIC MILESTONES, MUCH MORE WORK REMAINS TO BE DONE. TO THIS END, THE MRF FUNDS A SPECTRUM OF RESEARCH GRANTS, SCIENTIFIC INITIATIVES, AND PROGRAMS FOR CUTANEOUS MELANOMA AND RARER MELANOMA SUBTYPES (E.G. OCULAR, PEDIATRIC, ACRAL AND MUCOSAL MELANOMA). ITS RESEARCH GRANT PROGRAM IS A COMPETITIVE, PEER-REVIEWED RESEARCH GRANT PROGRAM FOR INVESTIGATOR-INITIATED RESEARCH HAS BEEN IN EXISTENCE SINCE 1998. MRF-SUPPORTED RESEARCH IS OPEN TO MEDICAL STUDENTS THROUGH SENIOR INVESTIGATIVE TEAMS.Expenses $2,947,330 · grants $1,629,606
- THE MRF'S ADVOCACY PROGRAM IS A PLATFORM FOR THOSE AFFECTED BY MELANOMA TO SHARE THEIR VOICE AND TRANSFORM POLICY. THE ADVOCACY AGENDA FOCUSES ON ISSUES ON BOTH THE STATE AND FEDERAL LEVEL. THE MAIN PILLARS OF THE PROGRAM ARE ACCESS, PREVENTION, EDUCATION AND FEDERAL FUNDING FOR MELANOMA RESEARCH.Expenses $1,099,138
- THE MRF HAS A ROBUST EDUCATION PROGRAM AIMED AT EDUCATING PATIENTS, PHYSICIANS AND THE GENEREAL PUBLIC ON PREVENTION, DIAGNOSIS, AND TREATMENT OF MELANOMA, AS WELL AS INCREASING OVERALL AWARENESS OF THE DISEASE. PROGRAMS INCLUDE WEBINARS, EDUCATIONAL MATERIALS, ANIMATED MELANOMA PATIENT VIDEOS, PATIENT/CAREGIVER SYMPOSIUMS AND RESOURCES SUCH AS SUPPORT GROUPS, CLINICAL TRIAL FINDER, TREATMENT CENTER FINDER AND ACCESS TO AN ONCOLOGY NURSE FOR NAVIGATION.Expenses $876,088
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in March, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | March 31, 2026 | August 17, 2026 | Not on file |
| 2024 | March 31, 2025 | August 15, 2025 | 990 on file |
| 2023 | March 31, 2024 | August 15, 2024 | 990 on file |
IRS record
- EIN
- 76-0514428
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1996
- Accounting year ends
- March
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Unknown (Z99)
- Assets (IRS master file)
- $8,283,039
- Income (IRS master file)
- $8,638,859
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | March 2025 | $7,413,825 | $6,905,774 | $8,283,039 | XML |
| 990 | March 2024 | $7,774,562 | $6,697,219 | $7,270,872 | XML |
| 990 | March 2023 | $6,578,223 | $6,478,760 | $6,173,374 | IRS |
| 990 | March 2022 | – | – | – | IRS |
| 990 | March 2021 | – | – | – | IRS |
| 990 | March 2019 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 76-0514428).
Questions about MELANOMA RESEARCH FOUNDATION
- What is the EIN of MELANOMA RESEARCH FOUNDATION?
- The employer identification number (EIN) of MELANOMA RESEARCH FOUNDATION is 76-0514428.
- Is MELANOMA RESEARCH FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1996.
- Are donations to MELANOMA RESEARCH FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does MELANOMA RESEARCH FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of MELANOMA RESEARCH FOUNDATION due?
- The return for tax year 2025 (the year ending March 31, 2026) is due August 17, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did MELANOMA RESEARCH FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended March 2025.
- Who is the principal officer of MELANOMA RESEARCH FOUNDATION?
- The 990 for the year ended March 31, 2025 names KYLEIGH LIPIRA.
- Who are the officers and directors of MELANOMA RESEARCH FOUNDATION?
- The 990 for the year ended March 31, 2025 lists 17 people; 4 received compensation from the organization, the highest $340,283 (KYLEIGH LIPIRA, CEO).
- How much revenue does MELANOMA RESEARCH FOUNDATION have?
- On its 990 for the year ended March 31, 2025 it reported revenue of $7,413,825, expenses of $6,905,774 and total assets of $8,283,039 at year end.
Other nonprofits in WASHINGTON
- SHARE OUR STRENGTH EIN 52-1367538 · last filed 990 for 2025
- NATIONAL ASSOCIATION OF COUNTY AND CITY HEALTH OFFICIALS EIN 52-1426663 · last filed 990 for 2025
- MORTGAGE BANKERS ASSOCIATION OF AMERICA EIN 36-1505650 · last filed 990 for 2025
- AMERICAN INDEPENDENT FOUNDATION EIN 33-1137541 · last filed 990 for 2024
- UNIDOSUS EIN 86-0212873 · last filed 990 for 2025
- NEW AMERICA FOUNDATION EIN 52-2096845 · last filed 990 for 2024
- THE ALBERT B SABIN VACCINE INSTITUTE INC EIN 06-1389829 · last filed 990 for 2024
- ST COLETTA OF GREATER WASHINGTON INC EIN 54-0968224 · last filed 990 for 2025
All nonprofits in WASHINGTON · District of Columbia · Unknown